Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Documenti analoghi

• Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
  di: Roelofs, A, et al.
  Pubblicazione: (2005)
• APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
  di: Croucher, P, et al.
  Pubblicazione: (2002)
• Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
  di: Roelofs, A, et al.
  Pubblicazione: (2007)
• Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
  di: Roelofs, A, et al.
  Pubblicazione: (2006)
• HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
  di: Aronson, J, et al.
  Pubblicazione: (1990)